Vanhoutte Frederic P.
|
| Dinamica numărului de publicaţii pe ani |  |  |
| Dinamica articolelor pe ani |  |
| Distribuirea numărului de pagini publicate pe categorii de reviste și ani | |
| Distribuirea articolelor pe domenii şi ani | |  | |
| Colaborarea autorului |  |  |
| Dinamica descărcărilor pe ani | |
Scopus Author ID Publicaţii peste hotare - 3.Publicații indexate în SCOPUS -
3. Publicații în H-index RM, Scopus -
(1).
- 4. Articole în reviste de peste hotare
- 4.1.Articole în reviste din WoS - 2
- 4.2.Articole în reviste din Scopus - 3
2019 - 1
|
Safety, pharmacokinetics, and antiviral activity of AT-527, a novel purine nucleotide prodrug, in hepatitis C virus-infected subjects with or without cirrhosis    |
Berliba Elina1  , Boguş Maxim1 , Vanhoutte Frederic P.2 , Berghmans Pieter Jan2 , Good Steven Spencer3 , Moussa Adel3 , Pietropaolo Keith3 , Murphy Robert L.34 , Zhou Xiaojian3 , Sommadossi Jean Pierre3 |
1 Timofei Moșneaga Republican Clinical Hospital,
2 SGS Life Sciences, Antwerp,
3 Atea Pharmaceuticals, Inc., Boston,
4 Northwestern University |
| Antimicrobial Agents and Chemotherapy |
| Vol. 63, / 2019 / ISSN 0066-4804 / ISSNe 1098-6596 |
| Disponibil online 4 December, 2019. Descarcări-0. Vizualizări-739 |
----------------------------------------------------------------------------------------------------------------------------------- 2017 - 2
|
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials  |
| Vanhoutte Frederic P.1 , Mazur Minodora2 , Voloshyn Oleksandr I.3 , Stanislavchuk Mykola4 , Van Der Aa Annegret1 , Namour Florence5 , Galien Rene5 , Meuleners Luc1 , Van't Klooster Gerben1 |
1 Galapagos NV, Mechelen,
2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
3 Chernivtsi Regional Clinical Hospital, Chernivtsi,
4 Vinnytsia Regional Clinical Hospital,
5 Galápagos SASU, Romainville |
| Arthritis and Rheumatology |
| Nr. 10(69) / 2017 / ISSN 2326-5191 |
| Disponibil online 7 February, 2018. Descarcări-1. Vizualizări-721 |
----------------------------------------------------------------------------------------------------------------------------------- | Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: Results from a randomised, dose-finding study (DARWIN 1) |
| Westhovens Rene12 , Taylor Peter Charles3 , Alten Rieke E.E.4 , Pavlova Dace5 , Enriquez-Sosa F.6 , Mazur Minodora7 , Greenwald Maria W.8 , Van Der Aa Annegret9 , Vanhoutte Frederic P.9 , Tasset Chantal9 , Harrison Pille9 |
1 Catholic University of Leuven (KU Leuven),
2 Department of Rheumatology, University Hospitals Leuven, Leuven,
3 University of Oxford,
4 Schlosspark-Klinik Innere Medizin II, Berlin,
5 LTD mandM CENTRS, Adazi,
6 CLINSTILE, S.A. de C.V, Mexico City,
7 Institute of Cardiology,
8 Desert Medical Advances, Palm Desert, CA,
9 Galapagos NV, Mechelen |
| Annals of the Rheumatic Diseases |
| Vol. 76, / 2017 / ISSN - / ISSNe 0003-4967 |
| Disponibil online 20 February, 2018. Descarcări-0. Vizualizări-916 |
-----------------------------------------------------------------------------------------------------------------------------------
